A detailed history of Douglas Lane & Associates, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 503,197 shares of MRK stock, worth $50.3 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
503,197
Previous 511,292 1.58%
Holding current value
$50.3 Million
Previous $63.3 Million 9.72%
% of portfolio
0.8%
Previous 0.92%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$111.15 - $128.97 $899,759 - $1.04 Million
-8,095 Reduced 1.58%
503,197 $57.1 Million
Q2 2024

Jul 08, 2024

SELL
$123.8 - $132.96 $1.97 Million - $2.12 Million
-15,953 Reduced 3.03%
511,292 $63.3 Million
Q1 2024

Apr 11, 2024

BUY
$113.24 - $131.95 $2.69 Million - $3.14 Million
23,765 Added 4.72%
527,245 $69.6 Million
Q4 2023

Jan 17, 2024

BUY
$100.18 - $109.02 $114,405 - $124,500
1,142 Added 0.23%
503,480 $54.9 Million
Q3 2023

Oct 16, 2023

SELL
$102.95 - $114.33 $597,624 - $663,685
-5,805 Reduced 1.14%
502,338 $51.7 Million
Q2 2023

Jul 19, 2023

SELL
$108.61 - $118.38 $1.67 Million - $1.82 Million
-15,405 Reduced 2.94%
508,143 $58.6 Million
Q1 2023

Apr 17, 2023

SELL
$102.94 - $114.86 $1.5 Million - $1.68 Million
-14,584 Reduced 2.71%
523,548 $55.7 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $65,142 - $83,521
-745 Reduced 0.14%
538,132 $59.7 Million
Q4 2022

Jan 17, 2023

SELL
$87.44 - $112.11 $2.67 Million - $3.42 Million
-30,489 Reduced 5.35%
538,877 $59.8 Million
Q3 2022

Oct 14, 2022

SELL
$84.53 - $94.96 $329,836 - $370,533
-3,902 Reduced 0.68%
569,366 $49 Million
Q2 2022

Jul 18, 2022

SELL
$83.49 - $94.64 $519,892 - $589,323
-6,227 Reduced 1.07%
573,268 $52.3 Million
Q1 2022

Apr 25, 2022

SELL
$73.51 - $82.4 $278,308 - $311,966
-3,786 Reduced 0.65%
579,495 $47.5 Million
Q4 2021

Jan 25, 2022

BUY
$72.28 - $90.54 $1.1 Million - $1.38 Million
15,249 Added 2.68%
583,281 $44.7 Million
Q3 2021

Oct 21, 2021

BUY
$71.68 - $78.83 $3.28 Million - $3.61 Million
45,775 Added 8.76%
568,032 $42.7 Million
Q2 2021

Jul 19, 2021

BUY
$70.31 - $77.77 $2.6 Million - $2.88 Million
37,018 Added 7.63%
522,257 $40.6 Million
Q1 2021

Apr 19, 2021

BUY
$68.86 - $81.11 $1.49 Million - $1.76 Million
21,704 Added 4.68%
485,239 $37.4 Million
Q4 2020

Jan 14, 2021

SELL
$71.77 - $79.65 $76,937 - $85,384
-1,072 Reduced 0.23%
463,535 $37.9 Million
Q3 2020

Oct 19, 2020

BUY
$73.18 - $82.95 $955,438 - $1.08 Million
13,056 Added 2.89%
464,607 $38.5 Million
Q2 2020

Jul 28, 2020

BUY
$70.42 - $80.13 $142,811 - $162,503
2,028 Added 0.45%
451,551 $34.9 Million
Q1 2020

Apr 20, 2020

SELL
$63.36 - $87.82 $1.73 Million - $2.4 Million
-27,371 Reduced 5.74%
449,523 $34.6 Million
Q4 2019

Jan 27, 2020

BUY
$77.58 - $87.54 $439,180 - $495,563
5,661 Added 1.2%
476,894 $43.4 Million
Q3 2019

Oct 16, 2019

SELL
$76.08 - $82.93 $328,969 - $358,589
-4,324 Reduced 0.91%
471,233 $39.7 Million
Q2 2019

Jul 08, 2019

SELL
$69.84 - $81.59 $1.2 Million - $1.4 Million
-17,160 Reduced 3.48%
475,557 $39.9 Million
Q1 2019

Apr 23, 2019

SELL
$69.58 - $79.36 $1.04 Million - $1.18 Million
-14,925 Reduced 2.94%
492,717 $41 Million
Q4 2018

Jan 17, 2019

SELL
$65.24 - $75.71 $827,569 - $960,381
-12,685 Reduced 2.44%
507,642 $38.8 Million
Q3 2018

Oct 09, 2018

BUY
$57.69 - $67.84 $17,768 - $20,894
308 Added 0.06%
520,327 $36.9 Million
Q2 2018

Jul 23, 2018

BUY
$50.83 - $59.72 $173,736 - $204,122
3,418 Added 0.66%
520,019 $31.6 Million
Q1 2018

Apr 23, 2018

BUY
$50.96 - $59.23 $3.09 Million - $3.59 Million
60,676 Added 13.31%
516,601 $28.1 Million
Q4 2017

Jan 24, 2018

BUY
$51.62 - $61.64 $1.12 Million - $1.34 Million
21,791 Added 5.02%
455,925 $25.7 Million
Q3 2017

Oct 19, 2017

BUY
$58.67 - $63.13 $25.5 Million - $27.4 Million
434,134
434,134 $27.8 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Douglas Lane & Associates, LLC Portfolio

Follow Douglas Lane & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.